health.wusf.usf.edu15 分钟
FTC sues insulin middlemen, saying they pocket billions while patients face high costs
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
FTC lawsuit claims drug middlemen are manipulating insulin market
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
FTC sues drug middlemen over manipulating the insulin market
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
wusf19 小时
The FTC has filed a lawsuit over the artificially inflation of the price of insulin
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
scrippsnews19 小时
FTC sues pharmaceutical middlemen, claiming practices inflated insulin cost
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...
FTC sues over allegedly inflated insulin prices
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
FTC sues pharmacy insurance managers, alleging unfair drug prices
The FTC accuses the largest pharmacy benefit manager companies of unfairly boosting prices on prescription drugs.
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
FTC sues three largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also 'on notice'
The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and UnitedHealth Group Inc., alleging that they artificially pumped up prices of insulin ...
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.